ibv
infecti
bronchiti
viru
lsu
larg
ribosom
subunit
prf
program
ribosom
frameshift
sfv
semliki
forest
viru
smfret
fret
ssu
small
ribosom
subunit
trit
trna
inhibit
therapi
translat
tightli
regul
step
gene
express
ensur
synthesi
protein
accord
sequenc
mrna
produc
transcript
ribosom
macromolecular
machin
synthes
protein
cell
control
accur
decod
mrna
triplet
respect
stringent
trna
select
mechan
ensur
low
overal
error
rate
mrna
decod
rang
time
amino
acid
incorpor
grow
peptid
chain
ribosom
move
one
codon
along
mrna
read
next
codon
keep
step
translat
even
essenti
prevent
missens
error
slippag
one
two
nucleotid
result
complet
alter
sequenc
synthes
peptid
fact
spontan
frameshift
error
rather
infrequ
per
codon
howev
case
rigor
read
frame
control
abrog
allow
ribosom
recod
genet
inform
respons
specif
stimulatori
signal
embed
mrna
sequenc
structur
program
ribosom
frameshift
prf
recod
event
allow
produc
multipl
protein
mrna
shift
read
frame
forward
prf
backward
direct
slippag
occur
typic
nucleotid
although
shift
also
report
found
kingdom
life
includ
higher
eukaryot
particularli
preval
virus
mobil
genet
element
biolog
signific
prf
increas
capac
control
stoichiometr
ratio
protein
regul
gene
express
influenc
mrna
stabil
mani
human
pathogen
virus
requir
frameshift
viabil
ensur
product
certain
viral
enzym
encod
modul
ratio
viral
structur
protein
necessari
virion
assembl
among
viral
protein
produc
upon
mani
contribut
viral
infect
either
directli
evad
host
antivir
respons
indirectli
hinder
viral
particl
format
releas
therebi
decreas
viral
titer
review
summar
recent
progress
understand
mechan
includ
differ
rout
mechan
lead
altern
read
frame
exampl
frameshift
call
altern
slippag
addit
two
case
avian
infecti
bronchiti
viru
ibv
bacteri
dnax
focu
exampl
two
phylogenet
distant
human
virus
human
immunodefici
viru
type
semliki
forest
viru
sfv
show
trna
abund
modul
rout
effici
discuss
differ
rout
addit
slipperi
site
result
robust
need
viru
life
cycl
typic
govern
two
slipperi
site
ss
downstream
mrna
secondari
structur
fig
ss
repetit
heptanucleotid
sequenc
type
allow
two
trna
read
codon
xxi
yyz
xxx
yyy
codon
slippag
mrna
secondari
sl
pseudoknot
pk
kiss
loop
roadblock
hinder
transloc
therebi
promot
frameshift
addit
sequenc
bacteria
protein
virus
mirna
mammalian
cell
modul
effici
case
structur
downstream
mrna
secondari
structur
known
bioinformat
chemic
probe
mutagenesi
structur
studi
exampl
pk
frameshift
site
ibv
discov
base
mutat
analysi
structur
predict
bioinformat
fig
wherea
atom
structur
pk
still
lack
structur
sl
bacteri
dnax
initi
suggest
base
mutat
analysi
structur
probe
recent
studi
determin
structur
sl
bound
bacteri
ribosom
fig
sl
structur
one
exampl
mrna
secondari
structur
modul
structur
solv
use
mutagenesi
enzymat
probe
thermodynam
nmr
analysi
well
toeprint
chemic
probe
presenc
bacteri
ribosom
fig
secondari
structur
element
sfv
predict
extend
sl
bioinformat
mutat
analysi
valid
structur
chemic
probe
distinguish
rna
region
access
chemic
modif
fig
chemic
chosen
modifi
posit
nucleotid
base
region
protect
chemic
modif
due
base
pair
complementari
strand
modif
caus
stop
progress
revers
transcriptas
rt
result
product
short
cdna
fragment
visual
sequenc
fig
agreement
bioinformat
predict
sl
element
sfv
contain
long
lower
stem
encompass
nucleotid
ss
count
nucleotid
ss
seen
lack
chemic
modif
region
fig
c
nucleotid
form
small
unstructur
loop
lower
upper
stem
consist
access
modif
accord
bioinformat
analysi
also
belong
loop
howev
modif
statu
unclear
upper
stem
predict
span
nucleotid
howev
result
suggest
also
adjac
nucleotid
protect
modif
thu
might
belong
upper
stem
although
access
complementari
strand
nucleotid
nucleotid
unclear
fig
upper
stem
close
larg
bulg
span
nucleotid
predict
bioinformat
analysi
support
chemic
probe
data
nucleotid
predict
form
small
stem
appear
region
accord
chemic
probe
accord
bioinformat
analysi
base
pair
suggest
inaccess
chemic
modif
howev
case
inde
inaccess
modifi
addit
mutat
becom
protect
suggest
interact
pattern
complex
predict
final
confirm
presenc
predict
aguaau
loop
close
upper
stem
fig
henc
chemic
probe
larg
support
structur
sfv
sl
predict
bioinformat
analysi
major
differ
concern
length
upper
stem
appear
includ
nucleotid
base
chemic
probe
absenc
predict
small
stem
span
nucleotid
expect
ss
sequenc
nucleotid
ss
sl
nucleotid
show
high
degre
modif
indic
belong
sl
repres
spacer
two
frameshift
element
predict
bind
ribosom
start
codon
initi
complex
ic
affect
mrna
structur
like
ribosom
bind
mrna
region
distal
sl
fig
c
nucleotid
show
differ
reactiv
ic
free
wt
mrna
fig
c
howev
effect
like
caus
mutat
test
mrna
sequenc
introduc
ensur
translat
initi
e
coli
rather
presenc
ribosom
take
place
elong
phase
translat
due
lack
kinet
data
exact
time
recent
unknown
led
propos
number
differ
model
differ
time
elong
cycl
exampl
model
predict
occur
accommod
site
ribosom
integr
model
peptidyl
transfer
simultan
slippag
model
hybrid
state
format
transloc
dynam
model
state
ribosom
mechan
model
next
round
elong
requir
slippag
model
summar
lack
unifi
model
prompt
sever
group
investig
ensembl
kinet
singl
molecul
method
compar
result
obtain
previous
cellular
lysat
eg
rabbit
reticulocyt
lysat
vitro
assay
use
experi
advantag
provid
fulli
control
environ
everi
element
step
translat
elong
dissect
result
two
unrel
frameshift
exampl
gene
ibv
dnax
e
coli
suggest
occur
predominantli
trna
transloc
step
provid
support
model
list
follow
discuss
current
kinet
model
frameshift
frameshift
motif
ibv
gene
consist
ss
motif
encod
leu
uua
ly
aag
pk
posit
nucleotid
downstream
ss
fig
comparison
ensembl
kinet
singl
molecul
fluoresc
reson
energi
transfer
smfret
result
structur
intermedi
transloc
suggest
frameshift
occur
end
trna
move
e
p
site
respect
larg
ribosom
subunit
lsu
trna
anticodon
domain
yet
fulli
transloc
small
ribosom
subunit
ssu
frameshift
occur
two
trna
bound
ribosom
ribosom
adopt
conform
ssu
head
domain
swivel
rel
bodi
domain
trna
anticodon
place
intermedi
posit
respect
ssu
head
bodi
domain
chimer
respect
ssu
hybrid
lsu
state
interact
destabil
favor
frameshift
pk
structur
mrna
downstream
ss
imped
close
movement
ssu
head
domain
turn
hinder
releas
deacyl
trna
e
site
complet
transloc
presenc
mrna
secondari
structur
element
lead
translat
paus
open
kinet
window
trna
slip
differ
read
frame
notabl
appear
favor
translat
ribosom
shift
complet
transloc
releas
faster
remain
henc
could
consid
rescu
mechan
resolv
persist
translat
block
caus
secondari
structur
resum
translat
normal
rate
anoth
exampl
dnax
mrna
e
coli
slipperi
site
contain
ss
motif
encod
two
ly
aaa
aag
downstream
sl
sequenc
upstream
ss
fig
proce
via
two
altern
rout
one
ident
describ
ibv
wherea
activ
limit
studi
dnax
model
mrna
detail
use
smfret
mass
spectrometri
rapid
ensembl
kinet
smfret
ensembl
kinet
show
presenc
downstream
sl
hinder
transloc
wherea
rate
trna
deliveri
unchang
presenc
downstream
sl
dnax
mrna
also
hinder
trna
releas
shown
pk
ibv
paus
sl
ribosom
undergo
multipl
conform
transit
classic
hybrid
state
presenc
may
take
multipl
attempt
complet
transloc
ribosom
tri
resolv
secondari
structur
continu
canon
decod
preval
rout
correspond
slippag
mechan
suggest
earlier
similar
ibv
e
coli
dnax
anoth
pathway
frameshift
dnax
found
oper
site
remain
vacant
due
absenc
cognat
case
delay
decod
eventu
allow
slippag
singl
trna
ribosom
encount
codon
avail
normal
translat
resum
compar
hungri
frameshift
slow
requir
presenc
downstream
mrna
secondari
structur
also
smfret
experi
suggest
presenc
two
branch
point
determin
read
frame
one
transloc
describ
one
trnali
sampl
site
mass
spectrometri
optic
tweezer
data
suggest
transloc
ribosom
attempt
multipl
trajectori
excurs
along
mrna
slippag
new
frame
might
occur
differ
codon
mani
frameshift
attempt
fail
due
base
pair
mismatch
altern
frame
lead
accumul
incomplet
peptid
scenario
explain
mani
case
altern
frameshift
event
condit
vitro
translat
exampl
frameshift
frameshift
observ
dnax
may
explain
heterogen
frameshift
product
observ
previou
vivo
studi
hungri
frameshift
also
relat
common
mechan
frameshift
suppressor
trna
rescu
mrna
frameshift
mutant
frameshift
exampl
translat
defect
caus
g
insert
mrna
result
sequenc
rescu
mutat
trnaarg
read
aga
codon
delay
decod
allow
trnaglu
bound
gaa
codon
slip
restor
translat
given
ibv
e
coli
dnax
proce
via
slippag
question
aris
whether
mechan
util
case
well
earlier
propos
mechan
identifi
one
wide
known
case
overlap
prompt
us
studi
mechan
system
addit
studi
sfv
viru
phylogenet
distant
slipperi
site
sequenc
remark
degre
conserv
differ
viru
subtyp
follow
section
describ
mechan
two
mrna
take
place
gene
overlap
defin
ratio
structur
protein
capsid
gag
viral
enzym
chang
frameshift
effici
imped
viral
particl
format
detriment
viral
viabil
infect
notabl
mrna
result
two
differ
product
addit
peptid
although
numer
model
propos
explain
origin
biolog
signific
two
frameshift
product
remain
unknown
prompt
us
dissect
frameshift
event
mrna
use
vitro
reconstitut
translat
system
either
mammalian
bacteri
compon
report
effici
measur
report
vivo
human
cell
cultur
note
frameshift
effici
recapitul
bacteria
yeast
mammalian
cell
vivo
respect
vitro
translat
system
suggest
reli
highli
conserv
compon
translat
apparatu
frameshift
motif
consist
main
ss
sequenc
encod
phe
uuu
leu
uua
downstream
sl
element
fig
two
distinct
frameshift
product
one
contain
peptid
follow
amino
acid
sequenc
flr
one
phe
incorpor
instead
leu
follow
sequenc
ffr
fig
ratio
two
product
kinet
analysi
show
proce
via
two
rout
previous
describ
ibv
e
coli
dnax
mrna
fig
intriguingli
found
two
rout
depend
avail
uaa
read
uua
codon
fig
limit
suppli
uaa
decod
slow
ribosom
wait
trna
deliveri
bound
uuu
codon
slip
backward
anoth
uuu
codon
frame
result
chang
ident
codon
uua
uuu
incorpor
second
phe
peptid
give
rise
ffr
product
consist
earlier
suggest
fig
low
uaa
concentr
rate
leu
incorpor
lower
trnaph
slippag
henc
slippag
respect
ffr
rout
prevail
increas
uaa
concentr
incorpor
rate
increas
abolish
ffr
rout
favor
slippag
result
flr
pathway
frameshift
fig
along
kinet
data
one
main
argument
support
find
lack
competit
trnagli
trnaarg
read
codon
ggg
agg
follow
observ
indic
commit
happen
upon
leu
incorpor
prior
next
codon
decod
anoth
exampl
viral
frameshift
found
gene
alphaviru
sfv
defin
ratio
two
structur
protein
transfram
tf
play
role
envelop
protein
process
membran
permeabil
virion
assembl
viru
bud
contribut
infect
effici
sfv
measur
report
human
cell
probe
mrna
secondari
structur
element
mrna
fig
c
studi
mechan
describ
ibv
dnax
sfv
ss
sequenc
hypothes
sfv
also
result
two
peptid
case
ff
fl
depend
presenc
uaa
isoacceptor
fig
absenc
uaa
ff
product
form
yield
depend
concentr
fig
suggest
slippag
occur
prior
independ
trnaleu
uaa
incorpor
similarli
hungri
slippag
increas
uaa
concentr
effici
decreas
dramat
absenc
trnaleu
uaa
trnaleu
uaa
satur
fig
thu
ff
rout
sfv
oper
trnaleu
uaa
absent
limit
suppli
wherea
satur
translat
condit
fl
rout
becom
preval
better
understand
fl
regim
test
competit
bind
codon
follow
ss
gug
titrat
trna
presenc
equimolar
amount
trnaleu
uaa
molar
ratio
chang
frameshift
effici
appreci
fig
suggest
similarli
fl
product
result
dual
slippag
ss
trna
trnaph
trnaleu
uaa
late
stage
transloc
gug
codon
present
site
describ
isoacceptor
read
uua
codon
ss
sfv
act
main
modul
effici
defin
frameshift
rout
two
virus
interestingli
uua
codon
along
codon
rare
human
account
codon
gene
includ
gag
pol
uaa
dramat
underrepres
primari
target
cell
infect
human
less
abund
major
leu
isoacceptor
cag
high
demand
uaa
achiev
effici
gag
translat
may
addit
deplet
pool
free
uaa
cell
thu
decreas
avail
decod
frameshift
site
furthermor
trna
level
known
fluctuat
respons
interferon
activ
chang
gene
express
trigger
viral
infect
light
observ
ffr
flr
product
result
two
differ
rout
may
repres
adapt
strategi
viru
chang
avail
crucial
uaa
concentr
trnaleu
uaa
decreas
ribosom
switch
ffr
rout
lead
robust
therebi
maintain
stationari
frameshift
level
independ
small
trnaleu
uaa
fluctuat
realist
vivo
also
note
unlik
dnax
hungri
frameshift
pathway
activ
starvat
condit
use
hungri
ffr
flr
pathway
constitut
achiev
constant
effici
unlik
sfv
primarili
infect
neuron
cell
neuron
oligodendrocyt
level
trnaleu
uaa
known
thu
physiolog
relev
two
potenti
pathway
sfv
remain
elucid
given
low
level
trnaleu
uaa
human
question
remain
satisfi
high
demand
trna
achiev
effici
translat
gene
packag
cellular
trna
among
trnali
trnail
lesser
extent
trnaleu
uaa
virion
assembl
trna
packag
happen
passiv
govern
concentr
gradient
trna
must
present
cell
signific
concentr
multipl
indirect
indic
affect
trna
pool
yet
unknown
mechan
hiv
infect
chang
cellular
local
individu
synthetas
synthetas
complex
may
affect
aminoacyl
activ
virus
whose
genom
codon
usag
differ
host
alter
free
trna
pool
chang
trna
level
vaccinia
influenza
trna
misacyl
influenza
adenoviru
mechan
could
modul
trna
concentr
remain
unknown
along
sfv
extend
cag
repeat
human
huntingtin
mrna
also
modul
avail
expans
polyq
stretch
beyond
certain
threshold
lead
develop
progress
neurodegen
diseas
includ
huntington
diseas
spinocerebellar
ataxia
translat
extend
cag
repeat
result
deplet
trnagln
cug
recogn
cag
codon
deplet
pool
free
trna
turn
caus
effici
depend
length
polyq
stretch
like
proce
via
trna
hungri
slippag
mechan
discuss
dnax
ffr
sfv
ff
interestingli
trnagln
cug
show
express
level
human
lowest
concentr
trna
detect
brain
region
call
striatum
primari
site
huntington
diseas
summari
low
level
target
trna
link
increas
frameshift
level
accumul
mutat
huntingtin
protein
therebi
contribut
diseas
sever
huntington
patient
strong
inhibit
excess
amount
trnaleu
uaa
offer
potenti
new
approach
antivir
therapi
base
codon
usag
differ
retrovirus
human
host
multipl
trna
speci
predict
critic
retrovir
protein
synthesi
dispens
human
translat
lay
foundat
hypothet
trna
inhibit
therapi
trit
inactiv
trna
drastic
reduc
elong
rate
viral
protein
synthesi
leav
host
translat
unaffect
one
best
target
trit
could
exploit
retrovirus
trnaleu
uag
read
cua
leu
codon
furthermor
protein
schlafen
shown
select
inhibit
express
late
protein
manner
induc
select
cleavag
trna
long
variabl
loop
trnaser
trnaleu
mrna
harbor
multipl
uua
codon
translat
suscept
action
overexpress
due
trnaleu
uaa
deplet
recent
anoth
protein
shiftless
shown
dysregul
inhibit
replic
howev
potenti
use
antivir
therapi
remain
unclear
shiftless
bind
ribosom
frameshift
sequenc
mani
viral
even
human
cellular
mrna
frameshift
event
limit
ribosom
slip
nucleotid
exampl
ss
dnax
e
coli
support
also
even
frameshift
dsdna
tail
phage
tail
assembl
typic
regul
highli
conserv
event
howev
mu
phage
slippag
requir
instead
synthesi
human
antizym
requir
proceed
via
predomin
fission
yeast
result
bud
yeast
occur
via
slippag
presenc
empti
site
describ
hungri
porcin
reproduct
respiratori
syndrom
viru
util
slippag
ss
produc
differ
replicas
polyprotein
describ
exampl
slippag
requir
presenc
special
mrna
stimulatori
sequenc
downstream
ss
similar
enhanc
known
regul
note
small
amount
product
may
also
result
transcript
slippag
rna
polymeras
also
report
support
experi
frameshift
sequenc
place
unnatur
context
follow
antisens
site
prompt
studi
extent
altern
slippag
nativ
mrna
frameshift
site
inde
allow
even
slippag
contribut
overal
frameshift
effici
becom
signific
certain
omit
thu
altern
slippag
must
follow
hungri
rout
frameshift
ribosom
continu
translat
soon
encount
one
multipl
downstream
stop
codon
lead
prematur
termin
prematur
termin
often
use
upon
slippag
nonprogram
heptanucleotid
slipperi
site
abort
product
nonfunct
peptid
especi
condit
limit
prematur
termin
upon
frameshift
also
result
product
function
protein
one
exampl
e
coli
gene
copa
encod
copper
ion
transport
caus
prematur
termin
format
truncat
peptid
copa
z
turn
copper
chaperon
protect
cell
excess
copper
concentr
environ
hand
prematur
termin
upon
human
mrna
lead
mrna
degrad
decay
pathway
thu
regul
mrna
stabil
gene
express
hallmark
vast
genet
divers
rapid
evolut
particular
respons
antivir
therapi
potent
antivir
drug
target
proteas
cleav
polyprotein
yield
matur
function
viral
protein
one
gag
proteas
cleavag
site
locat
part
protein
encod
codon
downstream
cleavag
phe
leu
respons
antivir
treatment
proteas
inhibitor
proteas
gene
accumul
mutat
reduc
affin
proteas
inhibitor
simultan
impair
recognit
canon
cleavag
site
defect
partial
rescu
compensatori
mutat
cuu
uuu
result
leu
phe
substitut
creat
new
function
cleavag
site
enhanc
van
der
waal
interact
substrat
mutant
proteas
therebi
allow
process
mutat
also
turn
sequenc
support
ribosom
slippag
fig
mutat
slipperi
support
slippag
contribut
overal
frameshift
effici
depend
avail
fig
case
mutat
nativ
rescu
effici
suggest
contribut
frameshift
neglig
function
harbor
mutat
overal
frameshift
effici
remain
unchang
signific
amount
frameshift
observ
importantli
dysfunct
mutat
restor
effici
might
enough
sustain
viral
lifecycl
interestingli
viru
develop
altern
slipperi
site
respons
antivir
treatment
herp
simplex
virus
resist
acyclovir
treatment
accumul
mutat
thymidin
kinas
tk
gene
turn
previous
silent
repeat
g
c
nucleotid
function
slipperi
site
support
slippag
respect
thought
proceed
via
singl
trna
slippag
stimul
nonstop
mrna
presum
stall
ribosom
frameshift
event
provid
suffici
level
tk
thu
repres
rescu
mechan
viru
ensur
viabil
despit
damag
caus
antivir
therapi
frameshift
site
util
great
varieti
mrna
secondari
structur
element
despit
divers
seem
oper
via
two
major
evolutionari
conserv
kinet
pathway
slippag
transloc
slippag
limit
suppli
trna
decod
codon
choic
frameshift
pathway
defin
avail
trna
read
slipperi
site
codon
crucial
import
pathogen
virus
whose
codon
usag
differ
host
pathogen
virus
develop
differ
strategi
util
altern
frameshift
rout
newli
emerg
slipperi
site
altern
slippag
ensur
robust
frameshift
effici
thu
robust
viral
cycl
progress
regardless
environment
chang
depend
slipperi
site
mrna
secondari
well
understood
wherea
list
factor
modul
frameshift
still
grow
recent
evid
suggest
multipl
protein
human
immun
system
influenc
effici
infecti
virus
act
directli
frameshift
site
compet
translat
resourc
small
interf
rna
repres
anoth
group
import
player
modul
frameshift
better
understand
factor
provid
novel
insight
mechan
frameshift
also
yield
necessari
understand
interact
coadapt
could
lay
foundat
futur
therapeut
approach
classic
antivir
therapi
target
key
compon
viral
life
cycl
lead
emerg
resist
viru
isol
due
select
pressur
high
mutat
rate
viral
genom
frameshift
site
especi
slipperi
heptam
repres
attract
target
antivir
drug
design
sequenc
highli
conserv
among
viru
subtyp
frameshift
often
determin
viru
viabil
attempt
develop
antiframeshift
therapeut
use
natur
synthet
molecul
far
succeed
clinic
trial
cytotox
effect
reli
highli
conserv
element
translat
machineri
make
like
viral
host
compon
target
recent
understand
frameshift
modul
suggest
exploit
host
cellular
resourc
could
becom
altern
approach
dysregul
frameshift
pathogen
virus
differ
codon
usag
human
host
strategi
worth
explor
would
chang
level
trna
crucial
decod
viral
frameshift
motif
dispens
host
translat
trnaleu
uaa
overexpress
human
gene
codon
usag
deplet
avail
translat
resourc
thu
remark
recod
interest
target
futur
medic
research
